Neupath Health Inc. (TSE:NPTH)
TSXV:NPTH
Canadian Market
Holding TSE:NPTH?
Track your performance easily

Neupath Health Inc. (NPTH) Stock Price & Analysis

2 Followers

NPTH Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

18.99%0.00%0.00%81.01%
18.99% Insiders
0.00% Other Institutional Investors
81.01% Public Companies and
Individual Investors

NPTH FAQ

What was Neupath Health Inc.’s price range in the past 12 months?
Neupath Health Inc. lowest stock price was C$0.14 and its highest was C$0.25 in the past 12 months.
    What is Neupath Health Inc.’s market cap?
    Currently, no data Available
    When is Neupath Health Inc.’s upcoming earnings report date?
    Neupath Health Inc.’s upcoming earnings report date is Nov 14, 2024 which is in 55 days.
      How were Neupath Health Inc.’s earnings last quarter?
      Neupath Health Inc. released its earnings results on Aug 15, 2024. The company reported C$0.005 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.005.
        Is Neupath Health Inc. overvalued?
        According to Wall Street analysts Neupath Health Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Neupath Health Inc. pay dividends?
          Neupath Health Inc. does not currently pay dividends.
          What is Neupath Health Inc.’s EPS estimate?
          Neupath Health Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Neupath Health Inc. have?
          Neupath Health Inc. has 54,498,550 shares outstanding.
            What happened to Neupath Health Inc.’s price movement after its last earnings report?
            Neupath Health Inc. reported an EPS of C$0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Neupath Health Inc.?
              Currently, no hedge funds are holding shares in TSE:NPTH
              ---

              Neupath Health Inc. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              12.50%
              12-Months-Change

              Fundamentals

              Return on Equity
              -0.34%
              Trailing 12-Months
              Asset Growth
              -3.80%
              Trailing 12-Months

              Company Description

              Neupath Health Inc.

              NeuPath Health Inc is a service provider in the highly fragmented chronic pain management market and operates around 12 chronic pain management clinics across Ontario under two brands CPM - Centers for Pain Management and InMedic Creative Medicine. Traditional medical treatments are supplemented with access to medicinal cannabis, NeuPath's Chronic Pain Self Management Program, and mindfulness meditation. In addition, the multimodal approach provides patients with the education and tools needed to help self-manage their chronic condition. NeuPath's provides patients with the care and tools they need to live a complete and fulfilled life; to reclaim the daily life activities that have been taken by injury or illness.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Hemostemix
              Alchemist Mining
              Newtopia
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis